Cargando…

Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients

BACKGROUND: Drugs that are used in COVID-19 infection, may interact with each other, as well as with the drugs for comorbidities, used concomitantly with COVID-19 treatment. OBJECTIVES: It is quite important to calculate and present the patients' exposure to clinically important potential drug-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kilit, Türkan Paşalı, Özyiğit, Filiz, Erarslan, Sertaş, Onbaşı, Kevser
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Makerere Medical School 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117511/ https://www.ncbi.nlm.nih.gov/pubmed/37092113 http://dx.doi.org/10.4314/ahs.v22i4.65

Ejemplares similares

Heart rate variability in normal-weight patients with polycystic ovary syndrome
por: Kilit, Celal, et al.
Publicado: (2017)

Report of a Family with Craniofrontonasal Syndrome and Wolff-Parkinson-White Syndrome: Is it a New Finding?
por: Kilit, Celal, et al.
Publicado: (2019)

Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients
por: Chen, Zhaoyan, et al.
Publicado: (2023)

Prevalence of polypharmacy and risk of potential drug-drug interactions among hospitalized patients with emphasis on the pharmacokinetics
por: Georgiev, Kaloyan D., et al.
Publicado: (2022)

Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean
por: Dookeeram, Darren, et al.
Publicado: (2017)

Potential for Drug Interactions and Polypharmacy From Treatment of COVID-19 in Long-Term Care
por: Blaszczyk, Amie Taggart, et al.
Publicado: (2022)

Polypharmacy and potential drug–drug interactions among Greenland’s care home residents
por: Albertsen, Nadja, et al.
Publicado: (2022)

Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
por: Bachmann, Paula, et al.
Publicado: (2022)

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms
por: Krečak, Ivan, et al.
Publicado: (2023)

Drug-drug interactions in polypharmacy patients: The impact of renal impairment
por: Papotti, Bianca, et al.
Publicado: (2021)

Targeting continuity of care and polypharmacy to reduce drug–drug interaction
por: Weng, Yi-An, et al.
Publicado: (2020)

Polypharmacy and potential drug–drug interactions for people with HIV in the UK from the Climate‐HIV database
por: Okoli, C, et al.
Publicado: (2020)

A study of harmful drug–drug interactions due to polypharmacy in hospitalized patients in Goa Medical College
por: Khandeparkar, Akshay, et al.
Publicado: (2017)

The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan
por: Nusair, Mohammad B., et al.
Publicado: (2020)

Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
por: Sheikh-Taha, Marwan, et al.
Publicado: (2021)

Polypharmacy and Potential Drug–Drug Interactions in Home-Dwelling Older People – A Cross-Sectional Study
por: Hermann, Monica, et al.
Publicado: (2021)

Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV
por: Courlet, Perrine, et al.
Publicado: (2019)

Using INTERCheck(®) to Evaluate the Incidence of Adverse Events and Drug–Drug Interactions in Out- and Inpatients Exposed to Polypharmacy
por: Martocchia, Antonio, et al.
Publicado: (2020)

Prescription Advice Based on Data of Drug-Drug-Gene Interaction of Patients with Polypharmacy
por: Salamone, Sandro, et al.
Publicado: (2022)

Determination of the Perception Level of Life Style Innovations in Type 2 Diabetes Mellitus
por: Korkut, Yasemin, et al.
Publicado: (2019)

Prevalence of Polypharmacy and Drug Interaction Among Hospitalized Patients: Opportunities and Responsabilities in Pharmaceutical Care
por: Trumic, Edisa, et al.
Publicado: (2012)

Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review
por: Rodrigues, Maria Cristina Soares, et al.
Publicado: (2016)

POLYPHARMACY VERSUS DRUG COMBINATIONS
por: Agarwal, A.K.
Publicado: (1991)

Polypharmacy and the occurrence of potential drug–drug interactions among geriatric patients at the outpatient pharmacy department of a regional hospital in Durban, South Africa
por: Bojuwoye, Adetola Olaniyi, et al.
Publicado: (2022)

The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010
por: Guthrie, Bruce, et al.
Publicado: (2015)

The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
por: Frahm, Niklas, et al.
Publicado: (2020)

Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region
por: Burato, Sofia, et al.
Publicado: (2021)

Polypharmacy, Potentially Inappropriate Medications, and Drug-Drug Interactions in Vulnerable Older Adults With Advanced Cancer Initiating Cancer Treatment
por: Ramsdale, Erika, et al.
Publicado: (2022)

Survey on Polypharmacy and Drug-Drug Interactions Among Elderly People with Cardiovascular Diseases at Yekatit 12 Hospital, Addis Ababa, Ethiopia
por: Assefa, Yelbeneh Abayneh, et al.
Publicado: (2020)

Medication Appropriateness, Polypharmacy, and Drug-Drug Interactions in Ambulatory Elderly Patients with Cardiovascular Diseases at Tikur Anbessa Specialized Hospital, Ethiopia
por: Adem, Limi, et al.
Publicado: (2022)

Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender
por: Koh, Yvonne, et al.
Publicado: (2005)

Multimorbidity and Polypharmacy in Psychosis: Identifying Potentially Significant Drug Interactions in an Old Age Inpatient Psychiatry Setting
por: Tewari, Abhinav, et al.
Publicado: (2023)

Potential drug-drug interactions and their associated factors in hospitalized COVID-19 patients with comorbidities
por: Rahmadani, Imanda Dyah, et al.
Publicado: (2023)

Polypharmacy in chronic liver disease patients: Implications for disease severity, drug-drug interaction, and quality of life
por: Farooq, Juveriya, et al.
Publicado: (2023)

Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic
por: Cattaneo, Dario, et al.
Publicado: (2023)

Adverse drug reactions and polypharmacy in cardiac patients
por: Mugoša, Snežana, et al.
Publicado: (2012)

Polypharmacy - is there a cure for drug therapy problems?
por: Orehovački, Helena, et al.
Publicado: (2023)

Prescribed Versus Taken Polypharmacy and Drug–Drug Interactions in Older Cardiovascular Patients during the COVID-19 Pandemic: Observational Cross-Sectional Analytical Study
por: Anfinogenova, Nina D., et al.
Publicado: (2023)

Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy
por: Al Rihani, Sweilem B., et al.
Publicado: (2020)

Polypharmacy, potentially serious clinically relevant drug‐drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life
por: AL‐Musawe, Labib, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_60evajge6s7h8l9mhtmosgocrg